Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Cobalt sulphate heptahydrate; Propylene glycol
Chanelle Pharmaceuticals Manufacturing Limited
QA16QA
Cobalt sulphate heptahydrate; Propylene glycol
0.099, 99 percent weight/volume
Oral solution
LR: Licensed Retailer as defined in national legislation
Cattle, Goats, Sheep
Drugs for prevention and/or treatment of acetonemia
Vitamins and minerals
Authorised
1991-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Chanatol Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Oral solution. A clear, light pink coloured solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, sheep and goats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of acetonaemia in cattle and pregnancy toxaemia in sheep and goats. 4.3 CONTRAINDICATIONS Do not use in animals known to be hypersensitive to the active substances. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None known. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Wash splashes from the skin. Each ml contains: Active substances Cobalt sulphate heptahydrate 0.099 % w/v Propylene glycol to 100 % w/v For a full list of excipients, see section 6.1 I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _3_ _/_ _0_ _1_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _6_ _8_ _2_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None known at the correct dosage. 4.7 USE DURING PREGNANCY, LACTATION OR LAY The product may be used safely in pregnant and lactating animals. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known. 4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE For oral administration only. Shake well before use. Cat Les hele dokumentet